Oxford Society of Ageing and Longevity

Investing In Longevity
2024-04-11 12:00 - 13:00 UTC | Virtual
Overview: Join us for an enlightening online conversation with two visionary investors at the forefront of the longevity sector, Christian Angermayer and Lorenzo Thione. Dive into the world where technology intersects with the quest for a longer, healthier life. This event is a unique opportunity to explore the cutting-edge of investing in longevity, mental health, and the technologies set to revolutionize our future.
The Event:The Oxford Society of Ageing and Longevity is proud to present an exclusive online dialogue between Christian Angermayer, a leading figure in the psychedelic and longevity investment landscape, and Lorenzo Thione, a serial entrepreneur whose ventures span technology, art, and social value.
Christian Angermayer, with his profound portfolio including the world’s largest investment in psychedelics, aims to address the global mental health crisis through companies like atai Life Sciences. His ventures into longevity with Rejuveron Life Sciences and Cambrian Biopharma promise to extend human lifespan with quality health. As a founder and lead investor in multiple unicorns and decacorns, Christian’s expertise spans from FinTech & Crypto to Future Tech, showcasing a commitment to shaping a future where technology enhances life at every stage.
Lorenzo Thione stands at the intersection of innovation and social impact, with a history of founding and investing in companies that redefine industries. From Powerset’s integration into Microsoft Bing to producing Tony-award-winning Broadway shows, Lorenzo’s diverse portfolio highlights his unique blend of creativity and entrepreneurial acumen. An active supporter of the LGBT entrepreneurial community and a passionate investor in health, longevity, and performance optimization, Lorenzo’s investments reflect his commitment to societal betterment and individual well-being.
This conversation will bridge their collective insights on investing in technologies that promise not only to extend life but to enrich its quality. Attendees will gain unparalleled access to discussions on the future of health, the potential of psychedelics in mental health treatment, and the role of technology in shaping the longevity sector.
Please register to secure your virtual spot and mark your calendar for this exciting online event.
Christian Angermayer Biography:
Christian Angermayer is a visionary entrepreneur and investor, deeply involved in the advancement of the Next Human Agenda, focusing on technologies that enhance human life span and quality. As the founder of Apeiron Investment Group, with over USD 2.5 billion under management, Christian’s influence spans across Life Sciences, FinTech & Crypto, Future Tech, and beyond. His significant contributions to the field of psychedelics through atai Life Sciences, aim at revolutionizing mental health treatment. Furthermore, Christian’s passion for longevity is evident in his founding of biotech companies like Rejuveron Life Sciences and Cambrian Biopharma, which are at the forefront of developing therapies to extend human life and health spans. His broad portfolio reflects a commitment to leveraging technology for enhancing human health and happiness, making him a leading figure in the investment in life-extending innovations.
Lorenzo Thione Biography:
Lorenzo Thione is a distinguished serial entrepreneur and investor, known for his strategic intersections of technology, art, commerce, and social value. Beyond his success in co-founding companies like Powerset and his notable achievements in Broadway production, Lorenzo has carved a niche for himself in the longevity and health optimization space. His personal passion for enhancing human health and performance has translated into a series of targeted investments in cutting-edge health technologies. Among his notable contributions to the field are investments in Whoop, Levels, Vessel, Better Brand, Oura, Recess, Ergatta, Minicircle, Loyal, and Renewal, including some of Christian’s companies – Rejuveron, Cambrian Biopharma and Atai Life Sciences. through his involvement with Gaingels. These companies represent the forefront of health and wellness technology, focusing on everything from wearable fitness and health tracking devices to nutrition and longevity research. His role as an active investor and advisor in these ventures underscores his belief in the power of technology to enhance human well-being, positioning him as a key figure in the push towards a future where longevity and health optimization are within reach for all.

The $101 Million XPRIZE Healthspan: Insights from Prof. Jamie Justice
2024-03-06 18:00 - 20:00
Join us for an exclusive deep dive into the $101 Million XPRIZE Healthspan with Prof. Jamie Justice.
Location:
Fitzhugh Auditorium
Walton Street Oxford OX1 2HG
https://www.eventbrite.co.uk/e/the-101-million-xprize-healthspan-insights-from-prof-jamie-justice-tickets-854004529537?aff=oddtdtcreator

Investment Review in Longevity
2023-11-27 - 2023-12-03
Investment Opportunities in the Longevity Sector
Saïd Business School

Steve Horvath - Altos Lab
2023-11-15
Epigenetic Ageing Clocks in Mammals and Rejuvenation Strategies
Oxford Examination Schools East Wing
REGISTER NOW! – Organised by The Longevity Forum

Learning Longevity: Academic & Career Opportunities in Longevity Science
2023-11-06 19:00 - 20:00
ONLINE – Monday, Nov 6th: 7:00 pm UK / 2:00 pm NY /11:00 am PT
The Oxford Society of Aging and Longevity, in collaboration with the Harvard Aging Club, is excited to present a must-attend online talk featuring the SENS Research Foundation, a vanguard in aging and longevity research. This event is open to all and promises to be a significant gateway for those interested in the dynamic field of longevity science.
Event Description: “Learning Longevity: Academic and Career Opportunities in Longevity Science” will provide an in-depth look into the evolving landscape of longevity research. Highlights of the talk include:

Insights into the current and future state of longevity science.
Exploration of academic and professional paths in the field of aging and longevity.
An overview of SENS Research Foundation’s academic programs nurturing future scientists.
The synergy of cutting-edge research, student mentorship, and career development in the longevity sector.
This session is a unique chance for those aiming for a career in longevity research, curious about academic opportunities in this field, or simply fascinated by the science of anti-aging.

Speaker Bio: Our esteemed speaker, Lilli Fishman is the Director of Academic Affairs at SENS Research Foundation (SRF). At SRF Lilli is responsible for recruiting, selecting, placing, and mentoring students for SRF’s academic programs, including Summer, Postbaccalaureate, Graduate Internship, Master’s, and PhD programs. After students are selected, Lilli works with her team to plan curriculum and host regular meetings to develop student’s soft skills, with a special focus on helping students achieve their career goals and improve their scientific communication. Lilli is a research scientist by training. She earned her PhD in cellular and molecular biology from the University of Toledo where she led an international team of scientists to discover a unique sub-cellular structure that is critical in fertilization and development in human and cattle sperm. After that, she went on to become a USDA NIFA Fellow during her postdoctoral studies at the University of California, Davis, where she investigated the activation of the embryonic genome to eventually improve development rates in clinical and agricultural embryology settings. Lilli is passionate about solving life’s biggest problems: how we are born, and how we age – when combined with her drive to build equitable representation in advanced training opportunities, her goal is to to inspire and empower the next generation of pioneers in the field of anti-aging
About SENS Research Foundation: Leading the charge against age-related disease, the SENS Research Foundation is dedicated to developing therapies to cure and prevent the ailments of aging. Their innovative approach is reshaping the way age-related diseases are researched and treated, inspiring a new generation of biomedical scientists in the process.
About Harvard Aging Club: The Harvard Chan Student Aging Club is a student-run organization that aims to offer students a unique platform that blends the latest insights on aging-related topics with diverse perspectives from distinguished researchers, clinicians, entrepreneurs, and other professionals involved in the field. We are dedicated to fostering a vibrant community that brings together students who share an interest in the field of aging and helps them connect with impactful leaders whose work contributes to improving the lives of older adults.
Join Us: Don’t miss this exclusive opportunity to interact with a leading expert in longevity science. Discover the academic and career opportunities that lie within this intriguing field.
Please register to secure your virtual spot and mark your calendar for this exciting online event.
Register Today!

Continuing Education and Career Paths in Longevity
2023-11-06 - 2023-11-12

Can Ageing Be Solved?
2023-11-04
Prof. David Gems – UCL
Fitzhugh Lecture Theatre
Exeter College

DeSci & Longevity Biotech
2023-10-24 18:00
EPA lecture theatre – Lincon College
Oxford
Sign up: https://www.meetup.com/desci-oxford/events/296794257

Longevity Social
2023-10-21 19:00 - 22:45
Location: Exeter College Bar
Register Online

Private Yoga Session
2023-10-21 14:00 - 15:00
Register Online

Dr Evelyne Bischof: What is Longevity Medicine?
2023-07-13 16:30 - 17:30
The Oxford Society of Ageing and Longevity is delighted to present an exclusive online event featuring Prof. Evelyne Yehudit Bischof, MD, a specialist in Internal Medicine and renowned researcher in the fields of Oncology and Longevity Medicine. Join us on Thursday, July 13th at 4:30 pm UK time, 11:30 am NY time, or 11:30 pm Shanghai time, for an enlightening evening as we delve into the intersection of aging, healthcare, and longevity.
This online event offers a unique opportunity to hear directly from Dr. Evelyne Yehudit Bischof as she shares her vast knowledge and experiences in the areas of longevity medicine. Whether you are a medical professional, researcher, student, or simply intrigued by the emerging field of longevity medicine, this event promises to be enlightening and thought-provoking.
Dr. Evelyne Yehudit Bischof, is a trailblazer in the field of healthy longevity medicine, has a reputation that spans continents. Prof. Bischof serves as the Chief Physician Associate in the Department of Internal Medicine and Medical Oncology at the renowned University Hospital Renji, associated with Jiaotong University, Shanghai. She also holds the prestigious title of Professor of Medicine at Shanghai University of Medicine and Health Sciences. Prof. Bischof has solidified her stature as a leading medical professional through her comprehensive work in internal medicine, medical oncology, healthy longevity medicine, artificial intelligence in health, precision medicine, biogerontology, and geronto-oncology.
Prof. Bischof’s formidable reputation is further enhanced by her groundbreaking clinical work in the realm of longevity. Her role as the Director of the Longevity Department at Sheba Medical Center and as a longevity concierge physician at Human Longevity Inc. has placed her at the forefront of aging practice. This exceptional commitment to the advancement of longevity science is further demonstrated by her positions as the co-founder and Vice-president of the Healthy Longevity Medicine Society and as the Head of the Scientific Advisory Board for the Longevity Science Foundation. She has also showcased her research prowess through more than 150 peer-reviewed papers, contributing significantly to both Asian and European scientific literature.
The depth of Prof. Bischof’s professional expertise has been honed by her extensive clinical and academic work at premier institutions worldwide. After a decade of practice in Boston, New York, Shanghai, and Basel, she emerged as an expert in her field, boasting affiliations with high-profile institutions such as the University Hospital of Basel, Fudan Cancer Institute and Hospital, Zhongshan Hospital, and Shanghai East Hospital. The professor’s distinguished training record includes Harvard Medical School-affiliated hospitals such as Mass General Hospital, Beth Israel MD, Dana Farber Institute, and Columbia University NYC. She has also had the privilege to train in Fudan University hospitals, Shanghai, and University Hospitals of Zurich and Basel in Switzerland. Prof. Bischof’s engagement with the Swiss board as an internal medicine specialist further underscores her standing as a leading figure in global healthcare.

Decoding Aging in Dogs (and Humans!), with Dr. Matt Kaeberlein
2023-05-25 19:30 - 20:30
Decoding Longevity: Dogs, Humans, and the Shared Journey of Aging with Dr. Matt Kaeberlein
The Oxford Society of Ageing and Longevity is pleased to invite you to an exciting virtual event featuring Dr. Matt Kaeberlein, a leading researcher in the field of aging. As a Professor at the University of Washington (UW) School of Medicine and the Chief Science Officer at Optispan Ventures, Dr. Kaeberlein is dedicated to studying and understanding biological aging and how we can enhance our health as we age.
Mark your calendars for Thursday, May 25th at 7:30 pm UK time, as we embark on an exciting journey to the frontier of aging research. Dr. Kaeberlein’s groundbreaking work provides a fresh perspective on how we view aging, shifting the focus from lifespan to healthspan – the period of life spent in good health.
The talk will focus on his flagship Dog Aging project, where Kaeberlein is seeking to unlock the secrets of longer, healthier lives for our canine companions. In doing so, him and his team are fielding opportunities to translate outcomes to humans – adding a new definition to ‘mans best friend’.
Dr. Kaeberlein is co-founder and co-director of the pioneering Dog Aging Project. His unique approach of studying our canine companions brings a whole new dimension to the field. This project illuminates the common biological threads of aging across species, and importantly, identifies interventions that could promote healthspan in both dogs and humans!
Dr. Kaeberlein’s research covers a wide range of topics, from the effects of caloric and protein restriction to the potential health benefits of substances like rapamycin. His work helps us understand the complex interactions between genetics and the environment in the aging process.
We invite you to pre-submit your questions for Dr. Kaeberlein by emailing ageingandlongevity@gmail.com. There will also be a live Q&A session that will provide you with the opportunity to further engage with him during the event.
Join us in this exciting session as we explore the future of healthspan, aging, and longevity.
Don’t miss this opportunity – register today to secure your spot!

The Founding Father of Genetics, Prof. George Church: on Gene Therapy and Longevity
2023-05-03 14:00 - 15:00
The Oxford Society of Ageing and Longevity is delighted to invite you to a captivating online event featuring Dr. George Church, a visionary scientist and pioneer in the fields of genetics, synthetic biology, and gene therapy. A professor at both Harvard Medical School and MIT, Dr. Church consistently pushes the boundaries of scientific understanding, opening new possibilities for the future of human health and longevity.
Join us Wednesday, May 3rd. 7:00pm UK time, online, to explore the forefront of longevity research and the transformative potential of gene therapy in extending a healthy human lifespan. Dr. Church’s innovative contributions to genomic science include the development and optimisation of CRISPR-Cas9, a ground-breaking gene-editing technology that has revolutionized our ability to modify DNA with unparalleled precision. This revolutionary tool has not only deepened our understanding of genetic mechanisms but also paved the way for new treatments for genetic disorders and personalized medicine.
His recent work has focused on gene therapy for promoting health and extending lifespan. The first study, “A single combination gene therapy treats multiple age-related diseases,” published in 2019, investigates the potential of a single combination gene therapy to address multiple age-related diseases simultaneously. Using adeno-associated virus (AAV) vectors to deliver a combination of three longevity-associated genes in mice models, the
researchers observed significant improvements in various age-related diseases, such as heart and kidney diseases, obesity, and cognitive decline.
The second study, “New intranasal and injectable gene therapy for healthy life extension,” published in 2022, focuses on developing innovative gene therapy approaches to promote healthy life extension. The research explores the use of intranasal and injectable gene therapies to target cellular mechanisms associated with aging. The study demonstrates the potential of these novel therapies for promoting health and longevity in humans.
In the realm of synthetic biology, Dr. Church has co-developed Multiplex Automated Genome Engineering (MAGE), a method for large-scale, targeted manipulation of cellular genomes. This transformative technology has led to breakthroughs in environmental sustainability, such as engineering microbes to produce biofuels and sequester carbon dioxide, providing innovative solutions to some of the world's most pressing questions. As an advocate for open science, Dr. Church launched the Personal Genome Project, an ambitious initiative aimed at creating a public repository of human genomes and medical histories. This pioneering project seeks to accelerate the advancement of personalized medicine by making vital genetic data available to researchers worldwide.
Dr. Church’s research also delves into combating pathogens using novel approaches, such as phage-assisted continuous evolution (PACE). His work in this area holds the potential to revolutionize the way we fight infectious diseases and tackle antibiotic resistance, showcasing the transformative power of his scientific contributions. In addition to his numerous accomplishments, Dr. Church is a captivating speaker known for his ability to inspire audiences with his visionary ideas and dedication to pushing the frontiers of science.
You are encouraged to pre-submit your questions for by emailing ageingandlongevity@gmail.com. There will be a live Q&A session during the event, where you can ask your questions and engage in stimulating discussions with Dr. Church.
We look forward to welcoming you to this online event, as we explore the fascinating world of gene therapy, synthetic biology, and their potential contributions to human longevity.
Register now to secure your spot!
All the best,
The OSAL Committee
With special thanks to Marina Cerezuela, DPhil candidate in gene therapy, for development of the introductory text.

Viral sensation Bryan Johnson: on his quest to stay forever young
2023-03-15 18:00 - 19:00
Join the Oxford Society of Ageing and Longevity on Wednesday, March 15th at 6pm UK time for an exciting online talk with three leading figures who are helping to make longevity the next major social phenomenon.
Bryan Johnson, the “viral tech billionaire” who recently gained fame for his $2 million a year quest to reverse his biological age, will share his thoughts and experiences on his public effort. Bryan sparked a global conversation on age reversal, longevity science, and the future of preventative health. This includes the launch of the “Rejuvenation Olympics,” a global leaderboard that measures the most profound reversal of biological age.
Ryan Smith, VP of Tru-Diagnostics and co-host of the Rejuvenation Olympics, will also share insights into cutting-edge epigenetic age testing and technology that makes it possible for individuals to track their progress on their rejuvenation journeys.
Oliver Zolman, the MD who oversaw the team of clinicians working on Bryan’s health program, will also join and share his experiences working so closely with Bryan, and being given carte blanche to curate a cornucopia of evidence-based rejuvenation methods.
The audience will be invited to ask questions during a Q&A. You can also pre-submit questions by sending an email to ageingandlongevity@gmail.com.
Don’t miss out on this rare opportunity to hear from three prominent figures who are helping to promote longevity. Register now and join us on March 15th at 6pm UK time.
Bryan Johnson
Bryan Johnson is the world’s most measured human. Johnson sold his company, Braintree Venmo, to PayPal for $800m in 2013. Since then, he’s been investing millions to slow and reverse his aging. In 2021, he set a World Record by reducing his epigenetic age by 5.1 years in 7 months. Johnson publicly blogs, sharing at no cost his protocols, data and learnings for others to implement and improve upon. Project Blueprint, is an endeavor to achieve humanity and earth scale cooperation starting within Self.
In 2023, Johnson launched Rejuvenation Olympics, an epigenetic leaderboard assessing one’s speed of aging. Of the 1,750 people who have been using this state-of-the-art aging algorithm to track their progress longitudinally, Johnson ranks #1 in speed of age reduction.
Johnson is also the founder & CEO of Kernel, creator of the world’s first mainstream non-invasive neuroimaging system; and OS Fund, where he invested $100M in the predictable engineering of atoms, molecules, and organisms into companies now collectively valued over $6B. He is an outdoor adventure enthusiast, pilot, and author of children’s books, Code 7 and The Proto Project.
Oliver Zolman
Dr Oliver Zolman MBBS BSc is a medical doctor based in Cambridge, UK. His goal is to prove reversal of aging in each of the 81 organ types by 25% below chronological age by 2030, using Zolman Level 1, 2, 3 Protocol. Dr. Zolman teaches other clinicians how to implement this protocol via his Longevity School online course, based on gold standard clinical practice guidelines & biological aging clock biostatistics, with Zolman Aging Clocks covering all 81 organ types across imaging, device, biosample based markers.
Dr. Zolman has a visiting fellowship in Evidence-based Medicine from the University of Sydney, a 1st class degree in Regenerative Medicine & Biology of Aging from King’s College London, and attended the Accelerator at Cambridge University Judge Business School. He has published his novel Longevity Escape Velocity (LEVMED) specialty, taught in Longevity School, in the peer-reviewed journal Rejuvenation Research.
Dr Zolman has founded his own peer reviewed journal, the journal of Phenotypic Rejuvenation Human Case Reports & Biological Age Quantification Science, where he has published robust rejuvenation results as well as the Zolman Biological Age Marker (Z-BAM) Criteria; 21 biostatistical criteria that must be met for biological age and measurements and rejuvenation results to be biostatistically valid at N=1.
Sign up for the event!

Thought Leaders on the Frontline: Changing definitions of Ageing
2023-02-22 18:00 - 19:00 | Virtual
We are proud to announce a highly anticipated virtual conversation between Michael Hodin, CEO of the Global Coalition on Aging, and Dylan Livingston, Founder of the Alliance for Longevity Initiatives. The discussion will focus on the “Changing Definitions of Ageing” and the impact that demographic changes, advancements in medicine, and longevity science are having on our perceptions and fundamental definitions of aging.
The social, economic, and political implications of this shift are far-reaching and profound. On the social front, the new definition of aging will challenge long-standing stereotypes and prejudices about what it means to be old. On the economic front, the extended lifespan will have a profound impact on retirement planning and the workforce, requiring a rethinking of traditional models. On the political front, the changing definition of aging will require a reassessment of government policies on aging, from healthcare and social security to housing and employment.
As the global population continues to age, the Global Coalition on Aging and the Alliance for Longevity Initiatives are at the forefront of promoting a shift in perception from aging being a burden to an opportunity. Michael and Dylan will discuss the innovative ways in which they contribute to this change. Michael and Dylan will explore the elements of a multi-disciplinary and multi-stakeholder approach to tackle the challenges presented by an aging population, highlighting the collaboration between the public, private, and non-profit sectors.
Join us for this thought-provoking discussion as Michael and Dylan explore how longevity is re-shaping the future. The event will take place online – Wednesday, 22 February, 2023 at 18:00 UK time.
Register now to secure your spot!
Michael Hodin, Ph.D., CEO, Global Coalition on Aging
Michael W. Hodin, Ph.D. is CEO of the Global Coalition on Aging, Managing Partner at High Lantern Group, and a Fellow at Oxford University’s Harris Manchester College. He has spoken internationally on aging, including at G20, APEC, Davos, and the World Knowledge Forum.
The Global Coalition on Aging (GCOA) is a foremost international organization aimed at addressing the complex challenges and opportunities presented by the rapidly aging global population. Comprised of leaders from the public, private, and non-profit sectors, the coalition is committed to improving the quality of life for older people everywhere, against the backdrop of the transformational changes longevity science is posing.
Mike is a Member of the Council on Foreign Relations, and from 2010-2013, was Adjunct Senior Fellow with a focus on population aging. In 2013, Mike was invited by then-Committee Chairman Bill Nelson (D-FL) to lead a Members’ Roundtable with the U.S. Senate Special Committee on Aging. Mike was also the recipient of the 2012 Fred D. Thompson Award from the American Federation for Aging Research. He sits on the Boards of the Foreign Policy Association, Business Council for International Understanding, NYC Blood Center, American Skin Association, American Federation for Aging Research and Emigrant Savings Bank, where he is Chairman of its compensation committee. Mike was a member of the World Economic Forum’s Global Agenda Council on Ageing. And he sits on the Advisory Board for the Milken Institute Center for the Future of Aging.
Mike holds a BA, cum laude, Cornell University, M.Sc. from The London School of Economics, and M.Phil and Ph.D. from Columbia University.
Dylan Livingston, Founder, Alliance for Longevity Initiatives
Dylan V. Livingston is the Founder and CEO of the Alliance for Longevity Initiatives (A4LI), a 501(c)(4) nonprofit organization dedicated to advocating for the aging biotechnology industry and longevity movement.
The Alliance for Longevity Initiatives is the first and only 501(c)(4) nonprofit organization founded with the goal of creating social and political action around the issues of combating age-related chronic conditions and increasing our number of healthy, disease-free years. A4LI works with healthcare leaders and experts in the geroscience and regenerative medicine fields to drive awareness of the potential of longevity research amongst US government officials, and promote national-level support for the extension of healthy lifespans.
As an organization focused on advocating for political reform to aid in the growth and development of longevity initiatives, we are seeking to advance initiatives and policies that help progress longevity science in order to create a healthier future that everyone can enjoy.
As a self-proclaimed “son of the aging revolution,” he has been immersed in the longevity space since a young age. Prior to founding A4LI, Dylan gained valuable experience in political campaigns, including working for the Biden campaign in 2020 in Pennsylvania. He holds a B.S. in Physics from Haverford College, where he was also a four-year starting pitcher on the college’s baseball team.

Longevity Megatrend by Phil Newman
2023-01-18 18:00 - 20:00 | Saïd Business School, Park End Street, Oxford, OX1 1HP, United Kingdom
Why advances in science, macro-economic trends, and the basic desire of every human to want to live a long and healthy life, is creating the world’s biggest industry.
The talk will cover various megatrends shaping the longevity industry and will include a Q&A session followed by refreshments and lights bits at the end.
In his talk, Phil Newman, the Founder and CEO of Longevity.Technology, will explain what the longevity market is, highlight key scientific advances, explore the latest financial data, and look to the future of an exciting industry that is attracting both talent and investment capital.
$7.3bn was invested into longevity companies last year – doubling the amount invested in the previous year. Longevity has fast become a distinct business and investment category – this is your chance to get the inside track.

Longevity Megatrend by Phil Newman image
Phil Newman is Founder and CEO of www.Longevity.Technology the leading media and investment platform targeting the longevity sector.
In his career he has held c-level management positions; applying his marketing and business development expertise into: longevity, IoT, AI, medical devices, biopharma, 3D manufacturing, smartgrid and sustainability.
In 2018 he saw an opportunity in the emerging longevity field to create a media platform that addressed science, business and investment activity. Launched in 2019, www.longevity.technology rapidly became the leading news service with unparalleled domain authority enabling the company to expand its reach into investment brokerage, education and commerce.
Prior to switching his focus to the longevity sector, for 20+ years, Phil ran an international marketing consultancy specialising in market-entry and commercialisation strategies. The roster of successful engagements included several significant exits and 9-figure revenue generation programmes.

Crewdate with the FemTech, OxAI, and Biomedical Sciences societies.
2022-11-09 20:30 - 22:30 | Jamals, 107-108 Walton Street, Oxford, Oxfordshire, OX2 6AJ
Join us this week for a crewdate with the FemTech, OxAI, and Biomedical Sciences societies.
This would be a fantastic opportunity for people interested in frontier healthcare and technology to get together and discuss new ideas!
The event will be held at Jamal’s restaurant at Wednesday 9th November, between 8:30pm-10:30pm. Also this restaurant is cash-only so please bring at least £15.
There are limited spaces, so sign up ASAP!
Here is the google form to sign up: shorturl.at/xABFX
Check out our YouTube to see our previous talks (such as by Alex Zhavoronkov, PhD, CEO of Insilico Medicine) and stay tuned for more events!
